These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 17631146

  • 21. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
    Jensen EP, Poulsen SS, Kissow H, Holstein-Rathlou NH, Deacon CF, Jensen BL, Holst JJ, Sorensen CM.
    Am J Physiol Renal Physiol; 2015 Apr 15; 308(8):F867-77. PubMed ID: 25656368
    [Abstract] [Full Text] [Related]

  • 22. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
    Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M.
    Circulation; 2008 May 06; 117(18):2340-50. PubMed ID: 18427132
    [Abstract] [Full Text] [Related]

  • 23. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY, Lee SK, Jo KJ, Song DY, Lim DM, Park KY, Bonewald LF, Kim BJ.
    Life Sci; 2013 Mar 21; 92(10):533-40. PubMed ID: 23357248
    [Abstract] [Full Text] [Related]

  • 24. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat.
    Yang H, Li H, Wang Z, Shi Y, Jiang G, Zeng F.
    J Surg Res; 2013 Dec 21; 185(2):825-32. PubMed ID: 23890403
    [Abstract] [Full Text] [Related]

  • 25. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
    Hirata Y, Kurobe H, Nishio C, Tanaka K, Fukuda D, Uematsu E, Nishimoto S, Soeki T, Harada N, Sakaue H, Kitagawa T, Shimabukuro M, Nakaya Y, Sata M.
    Eur J Pharmacol; 2013 Jan 15; 699(1-3):106-11. PubMed ID: 23220706
    [Abstract] [Full Text] [Related]

  • 26. Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury.
    Marzioni M, Agostinelli L, Candelaresi C, Saccomanno S, De Minicis S, Maroni L, Mingarelli E, Rychlicki C, Trozzi L, Banales JM, Benedetti A, Baroni GS.
    Hepatology; 2014 Oct 15; 60(4):1324-35. PubMed ID: 24925797
    [Abstract] [Full Text] [Related]

  • 27. The murine glucagon-like peptide-1 receptor is essential for control of bone resorption.
    Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y, Inagaki N.
    Endocrinology; 2008 Feb 15; 149(2):574-9. PubMed ID: 18039776
    [Abstract] [Full Text] [Related]

  • 28. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S, Schimmer S, Oschmann J, Schiødt CB, Knudsen SM, Jeppesen CB, Madsen K, Lau J, Thøgersen H, Rudolph R.
    Biochemistry; 2007 May 15; 46(19):5830-40. PubMed ID: 17444618
    [Abstract] [Full Text] [Related]

  • 29. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
    Alpini G, Baiocchi L, Glaser S, Ueno Y, Marzioni M, Francis H, Phinizy JL, Angelico M, Lesage G.
    Hepatology; 2002 May 15; 35(5):1041-52. PubMed ID: 11981754
    [Abstract] [Full Text] [Related]

  • 30. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
    Tews D, Werner U, Eckel J.
    Horm Metab Res; 2008 Mar 15; 40(3):172-80. PubMed ID: 18348079
    [Abstract] [Full Text] [Related]

  • 31. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH.
    Arterioscler Thromb Vasc Biol; 2010 Jul 15; 30(7):1407-14. PubMed ID: 20448207
    [Abstract] [Full Text] [Related]

  • 32. Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis.
    Marzioni M, Alpini G, Saccomanno S, de Minicis S, Glaser S, Francis H, Trozzi L, Venter J, Orlando F, Fava G, Candelaresi C, Macarri G, Benedetti A.
    Gastroenterology; 2006 May 15; 130(6):1831-47. PubMed ID: 16697745
    [Abstract] [Full Text] [Related]

  • 33. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth.
    Nomiyama T, Kawanami T, Irie S, Hamaguchi Y, Terawaki Y, Murase K, Tsutsumi Y, Nagaishi R, Tanabe M, Morinaga H, Tanaka T, Mizoguchi M, Nabeshima K, Tanaka M, Yanase T.
    Diabetes; 2014 Nov 15; 63(11):3891-905. PubMed ID: 24879833
    [Abstract] [Full Text] [Related]

  • 34. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury.
    Goto H, Nomiyama T, Mita T, Yasunari E, Azuma K, Komiya K, Arakawa M, Jin WL, Kanazawa A, Kawamori R, Fujitani Y, Hirose T, Watada H.
    Biochem Biophys Res Commun; 2011 Feb 04; 405(1):79-84. PubMed ID: 21215253
    [Abstract] [Full Text] [Related]

  • 35. Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret.
    Lu Z, Percie Du Sert N, Chan SW, Yeung CK, Lin G, Yew DT, Andrews PL, Rudd JA.
    J Transl Med; 2014 Dec 10; 12():327. PubMed ID: 25491123
    [Abstract] [Full Text] [Related]

  • 36. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
    Li Y, Tweedie D, Mattson MP, Holloway HW, Greig NH.
    J Neurochem; 2010 Jun 10; 113(6):1621-31. PubMed ID: 20374430
    [Abstract] [Full Text] [Related]

  • 37. Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models.
    Chen Y, Li Z, Yang Y, Lin L, Zhang H.
    Int J Mol Med; 2013 Mar 10; 31(3):607-13. PubMed ID: 23338623
    [Abstract] [Full Text] [Related]

  • 38. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
    Willard FS, Wootten D, Showalter AD, Savage EE, Ficorilli J, Farb TB, Bokvist K, Alsina-Fernandez J, Furness SG, Christopoulos A, Sexton PM, Sloop KW.
    Mol Pharmacol; 2012 Dec 10; 82(6):1066-73. PubMed ID: 22930710
    [Abstract] [Full Text] [Related]

  • 39. Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids.
    Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, Christopoulos A, Sexton PM.
    J Pharmacol Exp Ther; 2011 Feb 10; 336(2):540-50. PubMed ID: 21075839
    [Abstract] [Full Text] [Related]

  • 40. Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis.
    Kim DI, Park MJ, Choi JH, Lim SK, Choi HJ, Park SH.
    Int J Biochem Cell Biol; 2015 Feb 10; 59():41-51. PubMed ID: 25483438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.